Literature DB >> 17655591

Blood use in elective surgery: the Austrian benchmark study.

Hans Gombotz1, Peter H Rehak, Aryeh Shander, Axel Hofmann.   

Abstract

BACKGROUND: Benchmarking transfusion activity may help to eliminate inappropriate use of blood products. The goal of this study was to measure and to compare the current transfusion practice and to identify predictors of transfusion in public hospitals to develop strategies to optimize transfusion practices. STUDY DESIGN AND METHODS: This was a prospective observational study in 18 randomly selected public hospitals from April 2004 to February 2005. Primary outcome measures were the amount of intra- and postoperative blood components transfused and intercenter variability of transfusion rate. Secondary outcome measures were prevalence of preoperative anemia, calculated perioperative blood loss, and lowest measured perioperative hemoglobin (Hb) level.
RESULTS: Adult patients undergoing primary unilateral total hip replacement (THR, n = 1401), primary unilateral knee replacement (TKR, n = 1296), hemicolectomy (HECOC, n = 148), and coronary artery bypass graft (CABG) surgery (n = 777) were enrolled. Due to the small number, data of HECOC patients were not fully analyzed. In the remaining procedures, there was a large intercenter variability in the percentage of patients who received transfusions: THR 16 to 85 percent, TKR 12 to 87 percent, and CABG 37 to 63 percent. In the patients who received transfusions, the number of red blood cells (RBC) units transfused varied significantly. There was also a considerable intercenter variability in RBC loss. The prevalence of preoperative anemia was 19 percent and identical in both sexes. The incidence of preoperative anemia was three times higher in patients who received transfusions compared to those who did not.
CONCLUSION: This study demonstrates a high intercenter variability in RBC transfusions and RBC loss in standard surgical procedures. Whereas the variability in blood loss remains largely unexplained, the main predictors for allogeneic RBC transfusions are preoperative and nadir Hb and surgical RBC loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655591     DOI: 10.1111/j.1537-2995.2007.01286.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  64 in total

Review 1.  [Patient Blood Management : three pillar strategy to improve outcome through avoidance of allogeneic blood products].

Authors:  H Gombotz; A Hofmann
Journal:  Anaesthesist       Date:  2013-07       Impact factor: 1.041

2.  Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit?

Authors:  Manuel Muñoz; Andrés Cobos; Arturo Campos
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

Review 3.  Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

Authors:  Elvira Bisbe; Misericordia Basora; María J Colomina
Journal:  Blood Transfus       Date:  2017-01-26       Impact factor: 3.443

4.  Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Elisa Martín-Montañez; Enrique Naveira; Javier Seara; José Pavía
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

5.  Blood transfusion practices: a little consistency please.

Authors:  Mark T Friedman
Journal:  Blood Transfus       Date:  2011-05-12       Impact factor: 3.443

Review 6.  Pre-operative anaemia: prevalence, consequences and approaches to management.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Arturo Campos; Joaquín Ruiz; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-06-16       Impact factor: 3.443

7.  Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer.

Authors:  Hong Man Yoon; Young-Woo Kim; Byung Ho Nam; Daniel Reim; Bang Wool Eom; Ji Yeon Park; Keun Won Ryu
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.

Authors:  Nael Hawi; Daniel Oliver Kendoff; Udo Hessling; Carl Haasper; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2014-05-11       Impact factor: 3.075

9.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

10.  Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland.

Authors:  Oliver M Theusinger; Stephanie L Kind; Burkhardt Seifert; Lain Borgeat; Christian Gerber; Donat R Spahn
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.